Lilian Reich

3.0k total citations · 1 hit paper
50 papers, 2.2k citations indexed

About

Lilian Reich is a scholar working on Hematology, Oncology and Surgery. According to data from OpenAlex, Lilian Reich has authored 50 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Hematology, 15 papers in Oncology and 10 papers in Surgery. Recurrent topics in Lilian Reich's work include Multiple Myeloma Research and Treatments (13 papers), Hematopoietic Stem Cell Transplantation (13 papers) and Neutropenia and Cancer Infections (6 papers). Lilian Reich is often cited by papers focused on Multiple Myeloma Research and Treatments (13 papers), Hematopoietic Stem Cell Transplantation (13 papers) and Neutropenia and Cancer Infections (6 papers). Lilian Reich collaborates with scholars based in United States and Italy. Lilian Reich's co-authors include Stephen Mackinnon, AP Gillio, Hugo Castro‐Malaspina, BH Childs, Farid Boulad, NA Kernan, Robert J. Motzer, Subhash C. Gulati, David Wuest and George J. Bosl and has published in prestigious journals such as Science, New England Journal of Medicine and Journal of Clinical Oncology.

In The Last Decade

Lilian Reich

49 papers receiving 2.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease

1995 600 citations Lilian Reich et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lilian Reich United States	25	1.3k	585	553	387	337	50	2.2k
Charles Linker United States	23	944 0.7×	657 1.1×	339 0.6×	191 0.5×	251 0.7×	58	2.1k
M Carotenuto Italy	26	1.1k 0.8×	680 1.2×	542 1.0×	374 1.0×	144 0.4×	81	2.2k
Gwynn D. Long United States	23	1.2k 0.9×	759 1.3×	542 1.0×	190 0.5×	135 0.4×	83	2.0k
A Grañena Spain	22	846 0.7×	426 0.7×	329 0.6×	250 0.6×	182 0.5×	86	1.6k
Subhash C. Gulati United States	25	1.3k 1.0×	903 1.5×	270 0.5×	561 1.4×	255 0.8×	86	2.8k
Edward Kanfer United Kingdom	26	1.1k 0.9×	477 0.8×	416 0.8×	229 0.6×	109 0.3×	55	1.8k
Anne Parker United Kingdom	23	1.0k 0.8×	1.1k 1.9×	567 1.0×	204 0.5×	177 0.5×	54	2.6k
Mitsuhiro Omine Japan	27	1.7k 1.3×	623 1.1×	993 1.8×	501 1.3×	94 0.3×	116	2.9k
Christophe Marzac France	19	1.7k 1.3×	366 0.6×	883 1.6×	516 1.3×	287 0.9×	58	2.5k
GW Santos United States	35	2.5k 1.9×	825 1.4×	950 1.7×	330 0.9×	342 1.0×	95	3.6k

Countries citing papers authored by Lilian Reich

Since Specialization

Citations

This map shows the geographic impact of Lilian Reich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lilian Reich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lilian Reich more than expected).

Fields of papers citing papers by Lilian Reich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lilian Reich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lilian Reich. The network helps show where Lilian Reich may publish in the future.

Co-authorship network of co-authors of Lilian Reich

This figure shows the co-authorship network connecting the top 25 collaborators of Lilian Reich. A scholar is included among the top collaborators of Lilian Reich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lilian Reich. Lilian Reich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Devlin, Sean M., Jill Vanak, Heather Landau, et al.. (2016). Upfront plerixafor plus G-CSF versus cyclophosphamide plus G-CSF for stem cell mobilization in multiple myeloma: efficacy and cost analysis study. Bone Marrow Transplantation. 51(4). 546–552. 38 indexed citations

Feldman, Darren R., Ilya Glezerman, Sujata Patil, et al.. (2015). Phase I/II Trial of Paclitaxel With Ifosfamide Followed by High-Dose Paclitaxel, Ifosfamide, and Carboplatin (TI-TIC) With Autologous Stem Cell Reinfusion for Salvage Treatment of Germ Cell Tumors. Clinical Genitourinary Cancer. 13(5). 453–460. 4 indexed citations

Feldman, Darren R., Ilya Glezerman, Sujata Patil, et al.. (2014). Phase I/II Study of Paclitaxel Plus Ifosfamide Followed By High-Dose Paclitaxel, Ifosfamide, and Carboplatin with Autologous Stem Cell Reinfusion for Salvage Treatment of Germ Cell Tumors. Biology of Blood and Marrow Transplantation. 20(2). S90–S90. 1 indexed citations

Nardone, Beatrice, Shenhong Wu, Benjamin C. Garden, et al.. (2013). Risk of Rash Associated With Lenalidomide in Cancer Patients: A Systematic Review of the Literature and Meta-analysis. Clinical Lymphoma Myeloma & Leukemia. 13(4). 424–429. 30 indexed citations

Landau, Heather, Alexander M. Lesokhin, Nikoletta Lendvai, et al.. (2013). Factors impacting stem cell mobilization failure rate and efficiency in multiple myeloma in the era of novel therapies: experience at Memorial Sloan Kettering Cancer Center. Bone Marrow Transplantation. 48(8). 1033–1039. 36 indexed citations

Modak, Shakeel, Irene Y. Cheung, Brian H. Kushner, et al.. (2011). Plerixafor plus granulocyte‐colony stimulating factor for autologous hematopoietic stem cell mobilization in patients with metastatic neuroblastoma. Pediatric Blood & Cancer. 58(3). 469–471. 25 indexed citations

Feldman, Darren R., Joel Sheinfeld, Dean F. Bajorin, et al.. (2010). TI-CE High-Dose Chemotherapy for Patients With Previously Treated Germ Cell Tumors: Results and Prognostic Factor Analysis. Journal of Clinical Oncology. 28(10). 1706–1713. 147 indexed citations

Cohen, Adam D., Ping Zhou, Joanne F. Chou, et al.. (2007). Risk‐adapted autologous stem cell transplantation with adjuvant dexamethasone ± thalidomide for systemic light‐chain amyloidosis: results of a phase II trial. British Journal of Haematology. 139(2). 224–233. 82 indexed citations

Kushner, Brian H., et al.. (2006). Topotecan, thiotepa, and carboplatin for neuroblastoma: failure to prevent relapse in the central nervous system. Bone Marrow Transplantation. 37(3). 271–276. 27 indexed citations

10.

Hassoun, Hani, Lilian Reich, Virginia M. Klimek, et al.. (2005). Doxorubicin and dexamethasone followed by thalidomide and dexamethasone is an effective well tolerated initial therapy for multiple myeloma. British Journal of Haematology. 132(2). 155–161. 29 indexed citations

11.

Smith, Lachlan J., et al.. (2001). Development of spontaneous factor VIII inhibitor in association with acute graft-versus-host disease. Bone Marrow Transplantation. 27(8). 887–889. 1 indexed citations

12.

Bae, Hyun W., et al.. (2001). The effect of preoperative donation of autologous blood on deep-vein thrombosis after total hip arthroplasty. Journal of Bone and Joint Surgery - British Volume. 83-B(5). 676–679. 6 indexed citations

13.

Motzer, Robert J., Madhu Mazumdar, Joel Sheinfeld, et al.. (2000). Sequential Dose-Intensive Paclitaxel, Ifosfamide, Carboplatin, and Etoposide Salvage Therapy for Germ Cell Tumor Patients. Journal of Clinical Oncology. 18(6). 1173–1180. 136 indexed citations

14.

Wuest, David & Lilian Reich. (1998). Apheresis: Principles and Practice. Journal of Clinical Apheresis. 13(1). 39–40. 26 indexed citations

15.

Fennelly, D., Jeffrey Schneider, D. Spriggs, et al.. (1995). Dose escalation of paclitaxel with high-dose cyclophosphamide, with analysis of progenitor-cell mobilization and hematologic support of advanced ovarian cancer patients receiving rapidly sequenced high-dose carboplatin/cyclophosphamide courses.. Journal of Clinical Oncology. 13(5). 1160–1166. 36 indexed citations

16.

Schneider, Jeffrey, John Crown, Carolyn Wasserheit, et al.. (1994). Factors affecting the mobilization of primitive and committed hematopoietic progenitors into the peripheral blood of cancer patients.. PubMed. 14(6). 877–84. 18 indexed citations

17.

Crown, John, Linda T. Vahdat, Lilian Reich, et al.. (1993). Rapid administration of multiple cycles of high-dose myelosuppressive chemotherapy in patients with metastatic breast cancer.. Journal of Clinical Oncology. 11(6). 1144–1149. 55 indexed citations

18.

Abboud, T. K., F. Swart, Amin Makar, et al.. (1988). TRANSNASAL ANALGESICS. Anesthesiology. 69(3A). A657–A657. 1 indexed citations

19.

Goldstein, Jack, et al.. (1982). Group B Erythrocytes Enzymatically Converted to Group O Survive Normally in A, B, and O Individuals. Science. 215(4529). 168–170. 119 indexed citations

20.

Garrett, Thomas J., James M. Woodruff, João L. Ascensão, et al.. (1977). EXACERBATION OF GVHD FOLLOWING REPEATED INFUSION OF IMMUNOCOMPETENT DONOR CELLS. Transplantation. 23(5). 448–450. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact